Developing targeted therapy for the treatment of colorectal, pancreatic and ovarian cancers

"Colorectal, pancreatic and ovarian cancer account for 25% of all cancer deaths in Australia. We propose to employ a so-called theranostic approach that has potential to treat these cancers. This approach is achieving significant improvements in survival and quality of life for patients with progressing neuroendocrine tumours and prostate cancers"

- Prof John Hooper, Mater Research - The University of Queensland